The Limited Reach of the HIPAA Security Rule
A comprehensive legal mandate for health data holders could better protect electronic health information.
HIPAA at 25 Remains a Work in Progress
HIPAA has delivered meaningful benefits to consumers but still needs updating to address new and emerging privacy challenges.
Reflecting on 25 Years of HIPAA
To commemorate the 25th anniversary of HIPAA’s passage, leading scholars explore the law’s impact on privacy and health care.
The Wild West of Fertility Clinics
Legal experts argue that the fertility industry is largely unregulated and poses risks to patients.
Regulatory Sandboxes Slowed the Spread of COVID-19
Scholar claims that regulatory sandboxes such as emergency use authorizations boost innovation, but at a cost.
Formaldehyde Lurks in Hair Products Despite FDA Warning
FDA warns consumers to protect themselves from a known carcinogen in hair smoothing products.
Regulating Drugs at a Discount
Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.
Discriminatory Blood Donation Policies Defy Science
COVID-19 highlights a blood donation deferral policy that clashes with modern science.
Something Fishy About Seafood Inspection
Government watchdog finds that FDA is not properly inspecting imported seafood.
Barriers to Maternal Health in Rural Areas
State policies create and exacerbate barriers to access rural health care.
Making Drugs Safe to Kill?
Lawyer proposes a new legal framework for reviewing FDA’s refusal to regulate lethal injection drugs.
Regulatory Control of Potentially Addictive Drugs
Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.